AI-09

AI-09 is an investigational injectable botulinum neuromodulator developed for the treatment of glabellar lines (frown lines). Unlike traditional botulinum toxin products that require reconstitution with saline before use, AI-09 utilizes a proprietary technology to provide a ready-to-use liquid formulation. This innovation aims to improve convenience and ease of administration for both clinicians and patients. In clinical trials, AI-09 demonstrated safety, tolerability, and efficacy in reducing glabellar wrinkles, with higher doses showing clinically significant results and a median duration of response up to 26 weeks (6 months). The mechanism of action is presumed similar to other botulinum toxins—blocking acetylcholine release at the neuromuscular junction—but has not been explicitly detailed in public sources[1][3].